Patents Represented by Attorney Gildo R. Fato
  • Patent number: 5326770
    Abstract: This invention relates to monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones, such as Formula I, to pharmaceutical compositions thereof, process of preparation, and methods of use in mammals to treat cognitive disorders, neurological dysfunction, and/or mood disturbances such as, but not limited to degenerative nervous system diseases.
    Type: Grant
    Filed: July 17, 1992
    Date of Patent: July 5, 1994
    Assignee: The Du Pont Merck Pharmaceutical Company
    Inventor: Wendell W. Wilkerson